Medtronic Names Dr. Laura Mauri as Chief Scientific, Medical, and Regulatory Officer

April 25, 2022—Medtronic announced that Laura Mauri, MD, has been appointed Medtronic Chief Scientific, Medical, and Regulatory Officer.

The appointment adds to Dr. Mauri’s previous responsibilities as Chief Clinical and Regulatory Officer, aligning and integrating the company’s scientific, medical, clinical research, and regulatory affairs under her leadership. Dr. Mauri will also continue to serve as a member of the Medtronic Executive Committee.

Dr. Mauri joined Medtronic in September 2018 and became a member of the company’s Executive Committee in August 2020. Before joining Medtronic, Dr. Mauri was a practicing interventional cardiologist for 15 years at the Brigham and Women’s Hospital in Boston, Massachusetts, and an internationally renowned investigator and professor of medicine at Harvard Medical School in Boston.

According to the company, Dr. Mauri has provided Medtronic with innovative leadership in trial design and data science, created new evidence pathways, provided medical and scientific input to investment decisions, delivered leadership to patient safety, and sponsored regulatory advances that have positively impacted patients worldwide.

The company advised that priorities for Dr. Mauri include delivering a transformative approach to both patient safety and patient engagement. She recently hired Olaf Hedrich, MD, MBBCh, a patient safety, risk, and analytics industry expert to serve as the company’s Chief Medical Safety Officer, responsible for leading an independent medical safety organization that will provide expert input to assure patients’ safety and quality across Medtronic products.

Dr. Mauri will also lead the integration of robust and independent medical expertise into the company’s business processes, including investment decisions, business development, exploration of therapeutic areas, and development of novel technologies, stated Medtronic.

Dr. Mauri succeeds Richard Kuntz, MD, as Chief Medical and Scientific Officer, who previously announced his retirement, effective April 29.

“Medtronic is fortunate to have world-leading experts across diverse scientific and medical fields who provide unique insights and breakthrough discoveries,” commented Dr. Mauri in the company’s press release. “I'm excited to integrate this expertise across our company, to connect technology innovation with better health outcomes for patients. A strong scientific and patient-centered mindset across all stages of device development will enable innovation that saves and improves lives.”

Medtronic’s chairman and CEO Geoff Martha added, “With this appointment, we’re enabling a patient-centered approach to healthcare technology innovation at every stage of the product lifecycle. Dr. Mauri’s expertise and leadership connects medical and scientific intelligence, ensuring we have a clear appraisal of the medical and scientific landscape as we make investment decisions, and helping to deliver effective and reliable innovations for patients and healthcare providers.”